JP2024519999A - 高い薬物充填量の中鎖脂肪酸トリグリセリドを有する安定な液体医薬組成物およびそれに関連する方法 - Google Patents

高い薬物充填量の中鎖脂肪酸トリグリセリドを有する安定な液体医薬組成物およびそれに関連する方法 Download PDF

Info

Publication number
JP2024519999A
JP2024519999A JP2023572714A JP2023572714A JP2024519999A JP 2024519999 A JP2024519999 A JP 2024519999A JP 2023572714 A JP2023572714 A JP 2023572714A JP 2023572714 A JP2023572714 A JP 2023572714A JP 2024519999 A JP2024519999 A JP 2024519999A
Authority
JP
Japan
Prior art keywords
liquid pharmaceutical
pharmaceutical composition
emulsion
present disclosure
forming excipients
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023572714A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024519999A5 (cg-RX-API-DMAC7.html
Inventor
リウ,アイクン・ジュリー
カースガールド,トーマス
シー ケイ バラチャンドラン,ムラリ ネア
ヘンダーソン,サミュエル・ティー
ボイド,ベンジャミン
Original Assignee
セレシン・インコーポレーテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by セレシン・インコーポレーテッド filed Critical セレシン・インコーポレーテッド
Publication of JP2024519999A publication Critical patent/JP2024519999A/ja
Publication of JP2024519999A5 publication Critical patent/JP2024519999A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Neurosurgery (AREA)
  • Dispersion Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Emergency Medicine (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Botany (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
JP2023572714A 2021-05-25 2022-05-25 高い薬物充填量の中鎖脂肪酸トリグリセリドを有する安定な液体医薬組成物およびそれに関連する方法 Pending JP2024519999A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163192826P 2021-05-25 2021-05-25
US63/192,826 2021-05-25
PCT/US2022/030819 WO2022251288A1 (en) 2021-05-25 2022-05-25 Stable liquid pharmaceutical compositions having high drug loadings of medium chain triglycerides and methods related thereto

Publications (2)

Publication Number Publication Date
JP2024519999A true JP2024519999A (ja) 2024-05-21
JP2024519999A5 JP2024519999A5 (cg-RX-API-DMAC7.html) 2025-06-02

Family

ID=82115983

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023572714A Pending JP2024519999A (ja) 2021-05-25 2022-05-25 高い薬物充填量の中鎖脂肪酸トリグリセリドを有する安定な液体医薬組成物およびそれに関連する方法

Country Status (10)

Country Link
US (1) US20240238199A1 (cg-RX-API-DMAC7.html)
EP (1) EP4346758A1 (cg-RX-API-DMAC7.html)
JP (1) JP2024519999A (cg-RX-API-DMAC7.html)
KR (1) KR20240012539A (cg-RX-API-DMAC7.html)
CN (1) CN117460495A (cg-RX-API-DMAC7.html)
AU (1) AU2022283278A1 (cg-RX-API-DMAC7.html)
CA (1) CA3220907A1 (cg-RX-API-DMAC7.html)
IL (1) IL308512A (cg-RX-API-DMAC7.html)
WO (1) WO2022251288A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA202311798B (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2024384650A1 (en) * 2023-11-26 2026-07-09 Cerecin Australia Pty Limited Formulations of lipid nano emulsions with controlled pharmacokinetic profiles and methods of making and using the same

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08505367A (ja) * 1992-10-16 1996-06-11 スミスクライン・ビーチャム・コーポレイション 医薬用エマルジョン組成物
JP2020510102A (ja) * 2017-03-15 2020-04-02 セレシン・インコーポレーテッド 高い薬物充填量の中鎖脂肪酸トリグリセリドを有する医薬組成物およびそれに関連する方法
WO2020180980A1 (en) * 2019-03-04 2020-09-10 Cerecin Inc. Medium chain triglyceride formulations with improved bioavailiblity and methods related thereto

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2553132T3 (es) * 2008-04-22 2015-12-04 Azelis Deutschland Kosmetik Gmbh Utilización de ésteres de ácido cítrico como emulsionantes W/O
BR112016018673B1 (pt) * 2014-02-14 2023-10-17 Jingjun Huang Composição em nanoemulsão de óleo em água estável opticamente clara, método de produção da mesma, e, formulação de carreador
US11857931B2 (en) * 2020-01-07 2024-01-02 WAKAMONO joint stock company Process for production of nano-microemulsion system of plant oil triglycerides

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08505367A (ja) * 1992-10-16 1996-06-11 スミスクライン・ビーチャム・コーポレイション 医薬用エマルジョン組成物
JP2020510102A (ja) * 2017-03-15 2020-04-02 セレシン・インコーポレーテッド 高い薬物充填量の中鎖脂肪酸トリグリセリドを有する医薬組成物およびそれに関連する方法
WO2020180980A1 (en) * 2019-03-04 2020-09-10 Cerecin Inc. Medium chain triglyceride formulations with improved bioavailiblity and methods related thereto

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
COLLOIDS AND SURFACES B: BIOINTERFACES, vol. 15, JPN6026020282, 1999, pages 117 - 125, ISSN: 0005865520 *
JOURNAL OF CONTROLLED RELEASE, vol. 105, JPN6026020281, 2005, pages 32 - 42, ISSN: 0005865519 *

Also Published As

Publication number Publication date
AU2022283278A1 (en) 2024-01-18
ZA202311798B (en) 2025-04-30
WO2022251288A1 (en) 2022-12-01
EP4346758A1 (en) 2024-04-10
KR20240012539A (ko) 2024-01-29
US20240238199A1 (en) 2024-07-18
IL308512A (en) 2024-01-01
CN117460495A (zh) 2024-01-26
CA3220907A1 (en) 2022-12-01

Similar Documents

Publication Publication Date Title
JP7573541B2 (ja) バイオアベイラビリティが改善した中鎖脂肪酸トリグリセリド製剤およびそれに関連する方法
US20230277459A1 (en) Pharmaceutical compositions having high drug loadings of medium chain triglycerides and methods related thereto
BRPI0407338B1 (pt) nutriente dietético ou suplemento alimentar compreendendo uma composição comestível, bem como uma composição farmacêutica oralmente administrável e respectivos usos
WO2022251288A1 (en) Stable liquid pharmaceutical compositions having high drug loadings of medium chain triglycerides and methods related thereto
CN116322659A (zh) 递送具有受控药物动力学、安全性和耐受性特性的中链甘油三酯的方法
HK40119699A (en) Medium chain triglyceride formulations with improved bioavailability and methods related thereto
HK40077205B (en) Pharmaceutical compositions having high drug loadings of medium chain triglycerides and methods related thereto
HK40077205A (en) Pharmaceutical compositions having high drug loadings of medium chain triglycerides and methods related thereto
HK40062099A (en) Medium chain triglyceride formulations with improved bioavailability and methods related thereto
HK40096010A (en) Methods for delivering medium chain triglycerides with controlled pharmacokinetic, safety and tolerability profiles
BR112019019098B1 (pt) Composição farmacêutica em pó seca por pulverização tendo alto carregamento de fármaco de triglicerídeos de cadeia média e seu método de produção
HK40014579B (en) Pharmaceutical compositions having high drug loadings of medium chain triglycerides and methods related thereto
HK40014579A (en) Pharmaceutical compositions having high drug loadings of medium chain triglycerides and methods related thereto

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250523

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20250523

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20260325

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20260521

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20260525

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20260706